-
141
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
Published 2025-01-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
142
Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis
Published 2025-01-01Subjects: Get full text
Article -
143
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Published 2025-02-01Subjects: Get full text
Article -
144
-
145
-
146
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
147
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Published 2024-12-01Subjects: Get full text
Article -
148
-
149
Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
150
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
151
Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancer
Published 2024-12-01Subjects: Get full text
Article -
152
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
153
-
154
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Published 2025-01-01Subjects: Get full text
Article -
155
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
156
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Published 2025-12-01Subjects: Get full text
Article -
157
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article -
158
The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
Published 2025-01-01Subjects: Get full text
Article -
159
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
Published 2025-03-01Subjects: Get full text
Article -
160